3050 companies

Nirvana Life Sciences

Market Cap: CA$410.0k

Engages in the research and development of therapeutic products to address addiction.

NIRV

CA$0.085

7D

0%

1Y

-88.7%

Mosaic ImmunoEngineering

Market Cap: US$5.7m

A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.

CPMV

US$0.79

7D

97.2%

1Y

-20.7%

Biomind Labs

Market Cap: US$1.2m

A biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.

BMND.F

US$0.016

7D

0%

1Y

-93.3%

GlobeStar Therapeutics

Market Cap: US$1.2k

A clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States.

GSTC

US$0.000001

7D

0%

1Y

-99.8%

Sirona Biochem

Market Cap: CA$15.8m

A cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France.

SBM

CA$0.06

7D

0%

1Y

9.1%

Provectus Biopharmaceuticals

Market Cap: US$31.0m

A clinical-stage biotechnology company, engages in developing immunotherapy medicines for various diseases in the United States.

PVCT

US$0.073

7D

-9.4%

1Y

-35.4%

NKGen Biotech

Market Cap: US$10.7m

A clinical-stage biotechnology company, develops cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells.

NKGN

US$0.15

7D

13.2%

1Y

-81.5%

WEED

Market Cap: US$6.1m

Focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.

BUDZ

US$0.038

7D

5.8%

1Y

-24.5%

Jolt Health

Market Cap: CA$572.8k

Operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada.

JOLT

CA$0.09

7D

0%

1Y

n/a

Actavia Life Sciences

Market Cap: US$7.7m

A leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia and lymphoma.

RASP

US$0.01

7D

0%

1Y

n/a

Zelira Therapeutics

Market Cap: AU$4.5m

A biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of a variety of medical conditions in Australia and the United States.

ZLD

AU$0.38

7D

-8.5%

1Y

-46.4%

Lionco Pharmaceutical GroupLtd

Market Cap: CN¥4.1b

Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, research and development, production, sales and medical services in China.

603669

CN¥5.80

7D

-3.0%

1Y

29.2%

Zhejiang Hisoar Pharmaceutical

Market Cap: CN¥9.8b

Engages in the manufacture of pharmaceutical products and dyes in China and internationally.

002099

CN¥6.19

7D

2.0%

1Y

14.4%

Beijing Hotgen Biotech

Market Cap: CN¥15.7b

Engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine.

688068

CN¥176.60

7D

-5.5%

1Y

632.2%

Pyridam Farma

Market Cap: Rp5.5t

Engages in the development, production, and trading of pharmaceuticals primarily in Indonesia.

PYFA

Rp490.00

7D

-19.7%

1Y

250.0%

KUKJEON PHARMACEUTICAL

Market Cap: ₩204.4b

Operates as a chemical total solutions provider in South Korea.

A307750

₩4,090.00

7D

3.7%

1Y

-0.7%

Hainan Haiyao

Market Cap: CN¥7.7b

Manufactures and sells pharmaceutical products and medical devices in China and internationally.

000566

CN¥5.92

7D

0.2%

1Y

45.1%

Tien Liang BioTech

Market Cap: NT$1.6b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

4127

NT$34.20

7D

-0.1%

1Y

-10.0%

Tibet Duo Rui Pharmaceutical

Market Cap: CN¥3.5b

Engages in the research and development, production, and sale of chemical pharmaceutical preparations and its raw materials in China.

301075

CN¥43.77

7D

14.6%

1Y

154.3%

Biome Grow

Market Cap: CA$562.1k

Focuses on the cannabis business.

BIO

CA$0.005

7D

0%

1Y

-50.0%

ChitogenX

Market Cap: CA$415.6k

An orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada.

CHGX

CA$0.005

7D

0%

1Y

-75.0%

Optimi Health

Market Cap: CA$22.2m

Operates as a GMP-certified pharmaceutical drug manufacturing company in Canada.

OPTI

CA$0.26

7D

13.3%

1Y

-19.0%

Nasus Pharma

Market Cap: US$72.3m

Operates as a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions.

NSRX

US$8.01

7D

-1.1%

1Y

n/a

Agentix

Market Cap: US$1.2m

A clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.

AGTX

US$0.032

7D

1.8%

1Y

-64.9%

Curative Biotechnology

Market Cap: US$8.5m

A development-stage biomedical company, develops, licenses, and commercializes pharmaceutical products and medical devices for patients with rare diseases.

CUBT

US$0.0093

7D

5.0%

1Y

-29.3%

BioNxt Solutions

Market Cap: CA$114.1m

Engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland.

BNXT

CA$0.92

7D

-9.8%

1Y

360.0%

Nymox Pharmaceutical

Market Cap: US$4.8m

A biopharmaceutical company, engages in the research and development of products for the aging population.

NYMX.F

US$0.043

7D

-28.3%

1Y

-69.3%

Ildong Pharmaceutical

Market Cap: ₩668.6b

Develops, manufactures, and sells pharmaceutical products in South Korea.

A249420

₩21,650.00

7D

-5.0%

1Y

59.1%

OliX Pharmaceuticals

Market Cap: ₩1.9t

A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.

A226950

₩93,100.00

7D

21.9%

1Y

452.9%

Foresee Pharmaceuticals

Market Cap: NT$12.9b

Operates as biopharmaceutical company in the United States, China, and Europe.

6576

NT$83.60

7D

4.5%

1Y

5.7%

Zhejiang Shapuaisi PharmaceuticalLtd

Market Cap: CN¥3.2b

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

603168

CN¥8.44

7D

1.8%

1Y

32.5%

Mycenax Biotech

Market Cap: NT$7.8b

Provides biopharmaceutical services and solutions for drug development and production in Taiwan.

4726

NT$37.80

7D

-3.6%

1Y

-17.5%

WPD Pharmaceuticals

Market Cap: CA$324.8k

Does not have any significant operations.

WBIO

CA$0.07

7D

0%

1Y

-44.0%

SOHM

Market Cap: US$4.4m

Develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.

SHMN

US$0.0015

7D

-11.4%

1Y

19.2%

Curatis Holding

Market Cap: CHF 55.7m

Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.

CURN

CHF 11.15

7D

-3.9%

1Y

59.3%

NovAccess Global

Market Cap: US$12.4k

A biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States.

XSNX

US$0.0002

7D

-33.3%

1Y

-97.3%

Page 72 of 85